Teacher Retirement System Of Texas Cerevel Therapeutics Holdings, Inc. Transaction History

Teacher Retirement System Of Texas

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$38.96 - $42.75 $7,597 - $8,336	-195 Reduced 1.21%	15,950 $652,000
Q1 2024 May 06, 2024	BUY	$40.88 - $43.27 $4,619 - $4,889	113 Added 0.7%	16,145 $682,000
Q4 2023 Feb 07, 2024	SELL	$20.27 - $42.44 $36,202 - $75,797	-1,786 Reduced 10.02%	16,032 $680,000
Q3 2023 Oct 31, 2023	BUY	$20.26 - $31.91 $16,572 - $26,102	818 Added 4.81%	17,818 $389,000
Q2 2023 Jul 19, 2023	SELL	$23.9 - $35.38 $54,085 - $80,064	-2,263 Reduced 11.75%	17,000 $540,000
Q1 2023 May 12, 2023	BUY	$22.82 - $35.32 $10,383 - $16,070	455 Added 2.42%	19,263 $470,000
Q4 2022 Feb 10, 2023	SELL	$25.35 - $31.96 $15,818 - $19,943	-624 Reduced 3.21%	18,808 $593,000
Q3 2022 Nov 03, 2022	BUY	$25.5 - $41.42 $258,570 - $419,998	10,140 Added 109.13%	19,432 $549,000
Q2 2022 Aug 09, 2022	BUY	$20.62 - $37.15 $2,742 - $4,940	133 Added 1.45%	9,292 $246,000
Q1 2022 May 09, 2022	BUY	$23.5 - $35.38 $18,682 - $28,127	795 Added 9.51%	9,159 $321,000
Q4 2021 Feb 10, 2022	BUY	$29.21 - $44.64 $44,691 - $68,299	1,530 Added 22.39%	8,364 $271,000
Q3 2021 Nov 09, 2021	BUY	$21.26 - $38.85 $145,290 - $265,500	6,834 New	6,834 $202,000

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.